Helping aids for the elderly Heredia

Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between Hepatitis C Virus and Head and Neck types of cancer. Journal for the National Cancer Institute. In Press.Economides MP, Mahale P, Kyvernitakis The, Turturo F, Kantarjian H, Naing The, Hosry J, Shigle TL, Kaseb The, Torres HA. Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected clients with cancer. Alimentary Pharmacology & Therapeutics. In Press.Mahale P, Torres HA, Kramer JR, Hwang LY, Li R, Brown EL, Engels EA. Hepatitis C virus illness as well as the risk of cancer tumors among elderly US adults: A registry-based case-control study. Cancer. In Press.Arcaini L, Besson C, Frigeni M, Fontaine H, Goldaniga M, Casato M, Visentini M, Torres HA, Loustaud-Ratti V, Peveling-Oberhag J, Fabris P, Rossotti R, Zaja F, Rigacci L, Rattotti S, Bruno R, Merli M, Dorival C, Alric L, Jaccard A, Pol S, Carrat F, Ferretti VV, Visco C, Hermine O. Interferon-free antiviral treatment in B-cell lymphoproliferative conditions related to hepatitis c virus infection. Blood. In Press.Varma The, Saliba RM, Torres HA, Afrough A, Hosing C, Khouri IF, Nieto Y, Shah ND, Parmar S, Bashir Q, Ahmed S, Jones RB, Kebriaei P, Olson The, Shpall EJ, Alousi AM, Qazilbash MH, Champlin RE, Popat UR. Results in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem mobile transplantation. Bone Marrow Transplantation 51(7):999-1001, 3/2016.Iqbal T, Mahale P, Turturro F, Kyvernitakis A, Torres HA. Prevalence and organization of hepatitis C virus illness with different forms of lymphoma. International Journal of Cancer 138(4):1035-7, 2/2016. PMID: 26356141.Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Antiviral treatment gets better total success in Hepatitis C virus-infected clients whom develop Diffuse Large B-cell Lymphoma. International Journal of Cancer 139(11):2519-28, 2016.Economides MP, Mahale P, Turturro F, Hosry J, Samaniego F, Granwehr BP, Torres HA. Development of Non-Hodgkin’s Lymphoma as an additional Improvement Non-Hodgkin Lymphoma as an additional Primary Cancer in Hepatitis C Virus-Infected Patients with a Different Primary Malignancy. Leukemia and Lymphoma Jun(27):1-4, 2016.Jain P, Verstovsek S, Wang W, Loghavi S, Torres HA, Estrov Z, Patel KP, Pemmaraju N. DNMT3A, TET2 and JAK2 mutations in polycythemia vera after long- term remission of secondary intense myeloid leukemia. Leukemia and Lymphoma 57(8):1969-73, 2016.Kyvernitakis A, Mahale P, Popat UR, Jiang Y, Hosry J, Champlin RE, Torres HA. Hepatitis C virus illness in clients undergoing hematopoietic mobile transplantation in the era of direct-acting antiviral agents. Biology of Blood and Marrow Transplantation 4(22):717-22, 2016.Torres HA, Vauthey JN, Economides MP, Mahale P, Kaseb A. Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing therapy. Journal of Hepatology 65(4):862-4, 2016.Kyvernitakis A, Torres HA, Jiang Y, Chamilos G, Lewis RE, Kontoyiannis DP. Preliminary Use of fusion Treatment doesn't affect Survival of 106 Patients with Hematologic Malignancies and Mucormycosis: a Propensity Score Analysis. Medical Microbiology and Disease 22(9):811.el-811.e8, 2016.Oliver NT, Nieto YL, Blechacz B, Anderlini P, Ariza-Heredia E, Torres HA. Serious hepatitis C reactivation as an earlier complication of hematopoietic mobile transplantation. Bone Marrow Transplantation, 2016.Mahale P, Turturro F, Romaguera JE, Fowler N, Torres HA. The result of Different Rituximab-Containing Chemotherapy Techniques on Hepatitis C Viremia. Leukemia and Lymphoma 57(6):1487-90, 2016. PMID: 26402559.Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller E, Borchardt R, Rashid The, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II. Transdisciplinary way of handling Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. The Journal of National Comprehensive Cancer system 14(9):1185-8, 2016.Torres HA, Chong PP, De Lima M, Friedman MS, Giralt S, Hammond SP, Kiel PJ, Masur H, McDonald GB, Wingard JR, Gambarin-Gelwan M. Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients. Biology of Blood and Marrow Transplantation 21(11):1870-82, doi: 10.1016/j.bbmt.2015., 11/2015. PMID: 26256943.Torres HA, Mahale P, Blechacz B, Miller ED, Kaseb The, Fowler N, Herlong HF, Jiang Y, Raad II, Kontoyiannis DP. Effect of Hepatitis C Virus disease in Patients with Cancer: dealing with a Neglected populace. Journal associated with the nationwide Comprehensive Cancer Network 13(1):41-50, 2015.Mahale P, Kaseb AO, Hassan MM, Torres HA. Hepatocellular carcinoma as another main disease in customers with chronic hepatitis C virus illness and a nonliver first major cancer. Digestion and Liver infection, 2015 47(4):348-9, 2015.Hwang JP, Granwehr B, Torres HA, Suarez-Almazor myself, Giordano TP, Barbo A, Lin HY, Fisch MJ, Chiao EY. HIV examination in patients with cancer tumors at the initiation of treatment at a big US extensive cancer tumors center. J Oncol Pract 11(5):384-390, 2015.Kyvernitakis A, Taremi M, Blechacz, B, Hwang J, Jiang Y, Mahale P, Torres HA. Impact of Hepatitis E Virus Seropositivity on Chronic Liver Disease of Cancer Patients with Hepatitis C Virus Infection. Hepatology Research(45):1146-51, 2015. PMID: 25488194.Mahale P, Thomas SK, Kyvernitakis The, Torres HA. Management of several myeloma difficult by hepatitis C virus reactivation - the part of new antiviral therapy. Open up Forum Infectious Dis 3(1):ofv211, 2015.Torres HA, Mahale P. Most clients with HCV-associated lymphoma present with moderate liver illness: A call to revise antiviral treatment prioritization. Liver Int 35(6):1661-4, 2015.Hassan MM, Abdel-Wahab R, Kaseb the, Phan with, El-Serag HB, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Shalaby A, Torres HA, Amos CI, Li D. immense Impact of Early Adulthood Obesity on Risk and Prognosis of Hepatocellular Carcinoma in the United States. Gastroenterology 149(1):119-29, 2015.Mahale P, Okhuysen PC, Torres HA. Does chemotherapy cause hepatitis C viral relapse in disease patients who had been successfully treated with antivirals? Clin Gastroenterol Hepatol 6(12):1051-1054, 2014.Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola GM, Ariza-Heredia E, Adachi JA, Chemaly RF, Marfatia R, Jiang Y, Mahale P, Kyvernitakis, Fanale MA, Mulanovich V. Efficacy and security of antiretrovirals in HIV-infected clients with cancer. Clin Microbiol Infect 20(10):O672-9, 2014. PMID: 24529214.Hwang JP, Suarez-Almazor myself, Torres HA, Palla SL, Huang DS, Fisch MJ, Lok ASF. Hepatitis C assessment in cancer clients receiving chemotherapy. J Oncol Pract. 3(10):167-74, 2014.Kyvernitakis A, Duvic M, Mahale P, Torres HA. Interferon-based Treatment for people with Mycosis Fungoides and Hepatitis C Virus Infection: an incident Series. Was J Clin Dermatol 15(5):451-6, 2014.Kyvernitakis A, Jabbour E, Torres HA. Sustained Virological reaction after 6 Weeks of Therapy with a First-generation Hepatitis C Virus Protease Inhibitor. Clin Infect Dis 58(9):1342-4, 2014.Torres HA, Kaseb the, Mahale P, Miller E, Frenette C. Telaprevir-containing program for remedy for hepatitis C virus illness in patients with hepatocellular carcinoma waiting for liver transplantation: an instance show. Journal of Hepatocellular Carcinoma(1):109-114, 2014.Torres HA, Mahale P, Miller ED, Oo TH, Frenette C, Kaseb AO. Coadministration of Telaprevir and Transcatheter Arterial Chemoembolization inside handling of Hepatitis C Virus-Associated Hepatocellular Carcinoma. World J Hepatol 5(6):332-5, 2013.Georgiadou SP, Lewis RE, Most Readily Useful L, Torres HA, Champlin R, Kontoyiannis DP. The impact of prior unpleasant mildew infections in leukemia clients who go through allo-SCT in the period of triazole-based secondary prophylaxis. Bone Marrow Transplant 48(1):141-3, 2013.Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Lewis R, Hwang J, Davila M, Torres HA. Acute exacerbation and viral reactivation of chronic hepatitis C disease in cancer clients. Journal of Hepatology 57(6):1177-85, 2012.Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE. An Adaptive Randomized test of Intermittent Dosing Plan of Aerosolized Ribavirin in Cancer Patients with Respiratory Syncytial Virus problems. Journal of Infectious Diseases 54(3):218-22, 2012.Torres HA, Adachi JA, Roach LR, Smith KM, Mahale P, Davila M, Raad II. Hepatitis C Clinic operated by Infectious disorder at an extensive Cancer Center – assist is along the way. Clinical Infectious Diseases 54(5):740-742, 2012.Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad II. Hepatitis C Virus Genotype Distribution changes by Underlying infection reputation among people in identical Geographic area: A Retrospective Multicenter research. J Clin Virol. 54(3):218-22, 2012.Mahale P, Kaseb AO, Davila M, Torres HA. The end result of Transcatheter Arterial Chemoembolization on Hepatitis C viremia. Oncologist 17(9):21-3, 2012.Aisenberg GM, Torres HA, Tarrand J, Safdar The, Bodey GP, Chemaly RF. Herpes virus Lower Respiratory System Infection in Patients with Solid Tumors. Cancer 115(1):199-206, 2009.Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in customers with hematologic malignancy. Disease 112(6):1282-7, 2008.Torres HA, Aguilera EA, Safdar The, Rohatgi N, Raad II, Sepulveda C, Luna M, Kontoyiannis DP, Chemaly RF. Fatal cytomegalovirus pneumonia in customers with haematological malignancies: an autopsy-based case–control research. Medical Microbiology and Infection 14:1160–6, 2008.Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human Herpesvirus-6 DNAemia in Immunosuppressed Adult people with Leukemia in danger for mildew disease. Haematologica 93(1):157-8, 2008.Raad II, Hanna HA, Boktour M, Jiang Y, Torres HA, Afif C, Kontoyiannis DP, Hachem RY. Novel antifungal agents as salvage therapy for unpleasant aspergillosis in clients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or perhaps in combination with caspofungin. Leukemia 22:496–503, 2008.Torres HA, Barnett B, Arduino RC. Alopecia associated to ritonavir-boosted atazanavir therapy. AIDS 21(10):1391-1392, 2007.Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Rohatgi N, Sepulveda C, Kantarjian HH, Safdar The, Raad II, Chemaly RF. Characteristics and upshot of Respiratory syncytial virus infection in customers with leukemia. Haematologica 92:1216-1223, 2007.Arias CA, Torres HA, Singh KV, Panesso D, Moore J, Wagner A, Murray BE. Failure of daptomycin monotherapy into the treatment of endocarditis caused by an Enterococcus faecium stress with vancomycin-resistant and prone subpopulations and proof in vivo loss of the vanA gene group. Clin Infect Dis 45:1343–6, 2007.Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar The, Raad II. Neuraminidase Inhibitors Increase upshot of people with Leukemia and Influenza Infection: An Observational research. Clin Infect Dis 44:964-7, 2007.Torres HA, Bull L, Arduino RC. Tongue Hyperpigmentation in a Caucasian Patient Coinfected With HIV and Hepatitis C During Peginterferon Alfa-2b and Ribavirin Therapy. Am J Gastroenterol 102(6):1334-1335, 2007.Torres HA, Barnett B, Arduino RC. Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected customers with glucose-6-phosphate dehydrogenase deficiency. Clin Infect Dis 44(6):887-8, 2007.Torres HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest Tube connected multidrug-resistant Staphylococcus aureus empyema: Could the upper body tube become coated with antiseptics? Infect Control Hosp Epidemiol 27(2):195-7, 2006.Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus illness in clients with lymphoma: an important reason for morbidity and mortality. Clin Lymphoma Myeloma 6(5):393-8, 2006.Torres HA, Chemaly RF, Storey R, Aguilera EA, Nogueras GM, Safdar A, Rolston KVI, Raad II, Kontoyiannis DP. Influence of types of cancer and hematopoietic stem cellular transplantation on medical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis 5(6):382-8, 2006.Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II. Cytomegalovirus Pneumonia in Patients with Lymphoma. Disease 104(6):1213-1220, 2005.Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal Cytomegalovirus Infection In Patients With Cancer. European Journal of Cancer 41(15):2268-2279, 2005.Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. Increased regularity of non-fumigatus Aspergillus types in amphotericin B- or triazole-pre-exposed cancer customers with positive cultures for aspergilli. Diagn Microbiol Infect Dis 52(1):15-20, 2005.Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Itraconazole put into a Lipid Formulation of Amphotericin B Does Not enhance Outcome of main remedy for Invasive Aspergillosis. Cancer 103(11):2334-7, 2005.Torres HA, Prieto VG, Raad II, Reddy BT, Kontoyiannis DP. Successful pulmonary cryptococcosis because capsule-deficient Cryptococcus neoformans doesn't differ clinically from proven pulmonary cryptococcosis because capsule-intact C. neoformans. Mycoses 48:21-24, 2005.Torres HA, Kontoyiannis DP, Rolston KVI. High-dose fluconazole therapy for cancer customers with solid tumors and candidemia: an observational, noncomparative retrospective study. Support Care Cancer 12(7):511-6, 2004.Steinbach WJ, Benjamin DK Jr, Kontoyiannis DP, Best JR, Lutsar We, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. Infections Due to Aspergillus terreus: A Multicenter Retrospective research of 83 instances. Clin Infect Dis 39(2):192–8, 2004.Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a Tertiary Care Cancer Center: danger aspects, Changing Spectrum and Determinants of Outcome. Scand J Infect Dis 36(8):564-569, 2004.Torres HA, Rivero GA, Lewis RE, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus types: Risk elements plus vitro susceptibility in contrast to Aspergillus fumigatus. Diagn Microbiol Infect Dis 46:25-28, 2003.Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand J, Han XY, Rolston KVI, Safdar The, Raad II, Kontoyiannis DP. Candidemia in a Tertiary Care Cancer Center: In Vitro Susceptibility and its particular Correlation with Outcome of Initial Antifungal treatment. Medicine (Baltimore) 82:309-21, 2003.Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and poisoning associated with caspofungin in conjunction with liposomal amphotericin B as primary or salvage remedy for pulmonary aspergillosis in customers with hematologic malignancies. Cancer 98(2):292-9, 2003.Torres HA, Bodey GP, Rolston KVI, Kantarjian HM, Raad II, Kontoyiannis DP. Attacks in Patients with Aplastic Anemia: knowledge at a Tertiary Care Cancer Center. Cancer 98(1):86-93, 2003.Rivero GA, Torres HA, Rolston KVI, Kontoyiannis DP. Listeria monocytogenes illness in clients with cancer. Diagn Microbiol Infect Dis 47:393-8, 2003.Torres HA, Bodey GP, Tarrand JJ, Kontoyiannis DP. Protothecosis in Patients with Cancer: cases show and literature review. Medical Microbiology and Infection 9:786-92, 2003.Reddy BT, Torres HA, Kontoyiannis DP. Breast Implant Infection Due To Trichosporon Beigelii. Scand J Infect Dis. 34(2):143-4, 2002.Torres HA, Rivero GA, Kontoyiannis DP. Endemic Mycoses in a Cancer Hospital. Medicine (Baltimore) 81(3):201-12, 2002.Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, Rolston KVI, Kontoyiannis DP. Nocardiosis in Patients with Cancer. Medicine (Baltimore) 81(5):388-97, 2002.Shaikh ZH, Torres HA, Walsh GL, Champlin RE, Kontoyiannis DP. Open Lung Biopsy in Bone Marrow Transplant Recipients Features a Poor Diagnostic Yield for a certain Diagnosis. Transpl Infect Dis 4(2):80-4, 2002.Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, Bodey GP, Raad II. Pulmonary candidiasis in customers with disease: an autopsy research. Clin Infect Dis 34(3):400-3, 2002.Torres HA, McDonald GB. How I address Hepatitis C virus illness in patients with hematologic malignancies. Blood 128(11):1449-57, 2016.Borchardt R, Torres HA. Challenges in handling Hepatitis C illness in disease patients. World Journal of Gastroenterology 11(20):2771-6, 2014.Torres HA, Mulanovich VE. Management of HIV illness in patients with cancer receiving chemotherapy. Clin Infect Dis. 59(1):106-14, 2014. PMID: 24642555.Torres HA, Davila M. Reactivation of Hepatitis B and Hepatitis C virus in customers with Cancer. Nat Rev Clin Oncol. 9(3):156-66, 2012.Torres HA, Arduino RC. Fosamprenavir calcium plus ritonavir for HIV illness. Consultant Rev Anti Infect Ther 5(3):349-63, 2007.Torres, HA. Febrile neutropenia: a summary. Pan American community of Infectology-Asociación Panamericana de Infectología 16, 2003.Torres HA, Raad II, Kontoyiannis DP. Infections brought on by Fusarium species. J Chemother 15:28-35, 2003.Torres HA, Chemaly RF. Viral disease or Reactivation in Patients during Treatment with Dasatinib: A call for assessment? Leuk Lymphoma 48(12):2308-9, 2007.Ellickalputhenpura feel, Torres HA. Histoplasmosis. JAAPA 25(12):18, 25-6, 2012. PMID: 23599999.Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: An Extensive Spectrum Triazole. Lancet Infect Dis 5(12):775-85, 2005.Hosry J, Samaniego F, Turturro F, Economides MP, Torres HA. Effectation of Lenalidomide on Hepatitis C Viremia in Cancer Patients: A Case Series. The 58th Annual Meeting of the United states community of Hematology, December 3-6, 2016, San Diego, California. 12/2016.Mahale P, Kyvernitakis The, Hosry J, Popat UR, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus disease in hematopoietic cellular transplant recipients. Bone Marrow Transplant Tandem Meeting, Honolulu, Hawaii, February 18 – 22, 2016.Economides MP, Mahale P, Kyvernitakis The, Turturo F, Kantarjian H, Naing A, Hosry J, Shigle TL, Kaseb The, Torres HA. Concomitant usage of antivirals and chemotherapy in hepatitis C virus-infected customers with cancer. EASL Specialized Conference: New Perspectives in Hepatitis C Virus Infection. The Roadmap for Cure, September 23-24, 2016, Paris, France. 2016.Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Effectation of antiviral therapy on overall success price in Hepatitis C virus-infected clients with Diffuse Large B-cell Lymphoma. The 52nd Annual Meeting of American community of Clinical Oncology (ASCO), Chicago, IL. Summer 3-7, 2016.Hosry J, Economides MP, Kaseb A, Hassan MM, Torres HA. Effectation of Sorafenib on Hepatitis C Viremia in Cirrhotic Patients with Hepatocellular Carcinoma. IDWeek 2016, October 26-30, New Orleans, Los Angeles. 2016.Hassan M, Abdel-Wahab R, Wolff RA, Botrus G, Shalaby the, Li D, Torres HA, Morris JS, Ballard K, Hawk E, Shalaby A, Amin HM, Yao JC, Lenzi R, Joss JA, Jalal PK, Khaderi S, Lacin S, Kaseb AO. Human growth hormone and Hepatocellular Carcinoma. The Liver Meeting® 2016, November 11-15, Boston, MA. 2016.Torres HA, Hosry J, Mahale P, Economides MP, Lok like. Hepatitis C virus reactivation in clients with disease: A prospective observational research of 91 clients. The Liver satisfying® 2016, November 11-15, Boston, MA. 2016.Hassan M, Abdel-Wahab R, Kaseb AO, Shalaby A, Botrus G, Lacin S, Morris JS, Amin HM, Wolff RA, Hwang JP, Li D, Torres HA, Shalaby the, Lenzi R, Yao JC, Joss JA, Jalal PK, Khaderi S, Ballard K, Hawk E. Hepatocellular Carcinoma Screening in High-Risk Populations in the United States. The Liver fulfilling® 2016, November 11-15, Boston, MA. 2016.Granwehr BP, Merriman KW, Shelal Z, Bazerbashi H, Brock PA, Gonzalez CE, Torres HA, Rice T. HIV Testing in a Cancer Center Emergency Department. The 2016 ASCO Quality Care Symposium, Phoenix, Arizona February 26-27, 2016.Hosry J, Kyvernitakis A, Mahale P, Champlin R, Torres HA. Interferon-Free Regimens in Hepatitis C Virus-infected Hematopoietic Cell Transplant Recipients. Bone Marrow Transplant Tandem Meeting, Honolulu, Hawaii February 18-22, 2016.Donato-Santana C, Oliver NT, Barbo AG, Lin H, Foreman JT, Torres HA, Granwehr BP, Chiao EY, Hwang JP. Management and medical Outcomes of Cancer Patients with Human Immunodeficiency Virus after Cancer Therapy. The SGIM 39th Annual fulfilling - Generalists Engaged in Population wellness, Hollywood Florida, might 11-14, 2016.Granwehr B, Merriman K, Grimes R, Shelal Z, Bazerbashi H, Brock P, Gonzalez C, Torres HA, Rice T. possible HIV, HBV, HCV Screening in a Cancer Center Emergency division. International Symposium HIV & Emerging Infectious conditions (ISHEID), Marseille, France, 2016.Economides MP, Mahale P, Hosry J, Jiang Y, Granwehr BP, Torres HA. Sofosbuvir-Based treatment in Patients with Chronic Hepatitis C Virus disease and Malignancies – A Prospective Observational learn of 60 customers. IDWeek 2016, October 26-30, New Orleans, Los Angeles. 2016.Mahale P, Kyvernitakis A, Kantarjian H, Naing A, Turturro F, Kaseb A, Torres HA. Concomitant usage of chemotherapy and antivirals in hepatitis C virus infected cancer clients. The Liver Meeting 2015® 66th Annual Meeting associated with the American Association when it comes to Study of Liver Diseases, November 13-17, 2015, San Francisco, CA. Hepatology 60(1)(suppl;abstr 1160), 2015.Kyvernitakis A, Mahale P, Popat UR, Jiang Y, Champlin RE, Torres HA. Hepatitis C virus infection in customers undergoing hematopoietic cell transplantation inside age of direct-acting antiviral representatives. The 51st Annual Meeting of American community Of Clinical Oncology, J Clin Oncol 33(suppl; abstr 7090), 2015. e-Pub 2015.Mahale P, Sturgis EM, Torres HA. Hepatitis C virus seropositivity and head and neck types of cancer – a fresh trio. The 51st Annual Meeting of United states community Of Clinical Oncology, J Clin Oncol 33(suppl; abstr 6041), 2015.Hwang JP, Granwehr B, Torres HA, Suarez-Almazor myself, Giordano TP, Barbo the, Lin HY, Fisch MJ, Chiao EY. HIV testing among customers with cancer before initiation of chemotherapy. The 38th yearly Meeting of the Society of General Internal Medicine (SGIM 2015) April 22-25, 2015, Toronto, Canada, 2015.Kyvernitakis the, Torres HA, Jiang Y, Chamilos G, Lewis RE, Kontoyiannis DP. Initial usage of Combination Treatment Does Not Impact Early Survival of 106 customers with Hematologic Malignancies and Mucormycosis: a Propensity get review. Submitted in-may 2015 toward Interscience meeting of Antimicrobial Agents and Chemotherapy (ICAAC) / International Congress of Chemotherapy and Infection (ICC). September 17–21, 2015, hillcrest, CA. and seventh Trends in Medical Mycology, 9-12 October, Lisbon, Portugal. 2015.Iqbal T, Mahale P, Turturro F, Kyvernitakis The, Torres HA. Prevalence of Hepatitis C Virus Infection in Patients with Lymphoma. The 51st Annual Meeting of American community Of Clinical Oncology, J Clin Oncol 33(suppl; abstr e19506), 2015.Kyvernitakis A, Mahale P, Torres HA. Security and tolerability of various antiviral regimens for chronic hepatitis c virus infection in disease customers. Hepatol Int 2015 9(Suppl, abstract 1235):S272, 2015.Kyvernitakis A, Mahale P, Sastry J, Torres HA. The result of sofosbuvir-based antiviral treatment on CD4+ T-cell counts in hepatitis C virus monoinfected disease clients. The Liver satisfying 2015® 66th Annual Meeting associated with the American Association for the research of Liver Diseases, san francisco bay area, CA. Hepatology November 13-17 60 (1)(suppl; abstr 1030), 2015.Torres HA, Roach L, Mahale P, Granwehr B, Blechacz B, Miller E, Borchardt R, Shukla B, Ericsson CD, Raad II. Transdisciplinary way of managing HCV infection in clients at a tertiary treatment cancer tumors center. ID Week 2015, October 7-11, Hillcrest, CA. Open Forum Infectious Diseases, 2015.Mahale P, Kaseb AO, Hassan M, Blechacz B, Kyvernitakis The, Torres HA*. Improvement hepatocellular carcinoma as a second major disease in hepatitis C virus-infected customers with an alternate main malignancy. 50th yearly Meeting of American community of Clinical Oncology (ASCO) Chicago, IL, might 30-June 3, J Clin Oncol 2014;32(15) (May 20 product): e150, 2014.Mahale P, Romaguera JE, Turturro F, Fowler N, Torres HA. Growth of Non-Hodgkin’s Lymphoma as 2nd main Cancer in Hepatitis C Virus-Infected Patients with a Different Primary Malignancy. The 56thAnnual Meeting of the United states community of Hematology, bay area, California. December 6-9, Blood 2014;(suppl; abstr 5414)., 2014.Mahale P, Thomas SK, Kyvernitakis A, Torres HA. Hepatitis C virus reactivation following thalidomide treatment. The United states Association for the learn of Liver Diseases, November 7-11, 2014, Boston, MA, at the American Association for learn of Liver Diseases (AASLD)/European Association for learn of Liver (EASL) 2014 Unique meeting on Hepatitis C. new york, NY. September 12 – 13, 2014.Rashid the, Torres HA, Jorewicz L, De Los Angeles Garza II R. frequency and attributes of despair in cancer patients with chronic Hepatitis C infection. 50th Annual Meeting of the United states community of Clinical Oncology (ASCO) Chicago, IL, May 30-June 3, J Clin Oncol 2014;32(15) (May 20 product): e205, 2014.Kyvernitakis A, Oo TH, Kroll MH, Afshar-Kharghan V, Mahale P, Torres HA. Incidence and handling of Hematological Toxicities connected with remedy for Hepatitis C Virus Infection in Cancer Patients. The 56thAnnual Meeting regarding the United states community of Hematology, San Francisco, California. December 6-9, Blood 2014;(suppl; abstr 4126), 2014.Torres HA, Mahale P. Many patients with hepatitis C virus (HCV)-associated lymphoma present with moderate liver disease at cancer analysis - A call to change indications for HCV therapy. The Liver fulfilling® 65th Annual Meeting of this United states Association when it comes to research of Liver Diseases, November 7-11, 2014, Boston, MA, and at the American Association for the learn of Liver conditions (AASLD)/European Association the research of Liver (EASL) 2014 Unique Conference on Hepatitis C. new york, NY. September 12-13, Hepatology 2014: 60 (4) suppl 1; abstr 1451, 2014.Varma A, Saliba RM, Torres HA, Afrough A, Hosing C, Khouri IF, Nieto Y, Shah ND, Parmar S, Bashir Q, Ahmed S, Jones RB, Kebriaei P, Shpall EJ, Alousi AM, Qazilbash MH, Champlin RE, Popat UR. Results and survival in hepatitis C virus seropositive lymphoma and myeloma customers after autologous stem mobile transplantation. The 79th Annual Meeting associated with United states university of Gastroenterology Philadelphia, PA. October 17-22, Am J Gastroenterol 2014; 109:suppl 2; abstr 2075, 2014.Abdel-Wahab R, Mohamed HE, Ahmed R, Kanwal PS, Kaseb A, Herlong HF, teenage KC, Botrus G, Torres HA, Shalaby like, Hassan M. Prognostic Effect of Statins on Hepatocellular Carcinoma in position and lack of Metformin intake. The Liver satisfying® 65th Annual Meeting associated with the United states Association for the Study of Liver Diseases. Boston, MA. November 7-11, Hepatology. 2014: 60 (4) suppl 1; abstr 1317, 2014.Mahale P, Kyvernitakis A, Torres HA. Q Predictors of Sustained Virological reaction in Cancer Survivors with Hepatitis C Virus disease obtaining Antiviral treatment. ID Week 2014. Philadelphia, PA, October 8-12, 2014.Mahale P, Fowler N, Romaguera JE, Turturro F, Torres HA. The Effect various Rituximab-Containing Chemotherapy Strategies on Hepatitis C Viremia. The 56th Annual Meeting associated with United states Society of Hematology, bay area, California. December 6-9, Blood 2014;(suppl; abstr 4448), 2014.Leon R, Martinez E, Guzman A, Torres HA. Reactivation of Hepatitis B. Emerging styles Conferences, 3/2013.Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola G, Ariza E, Chemaly RF, Jiang Y, Marfatia R, Shelburne S, Mulanovich V. Efficacy and protection of Antiretrovirals in HIV-Infected customers with Cancer. Abstract and Poster go at 53rd ICAAC, 2013.Torres HA, Mahale P, Raad II, Kontoyiannis DP. Hepatitis C Virus Infection in Patients with Cancer: A Single-Institution experience with 642 Patients. The Liver Meeting®, AASLD’s 64th Annual Meeting in Washington, DC, 2013.Hwang JP, Suarez-Almazor myself, Palla SL, Huang DS, Torres HA, Fisch MJ, Lok like. Hepatitis C virus evaluating before chemotherapy. The MASCC/ISOO 2013 Global Cancer Care Symposium. Berlin, Germany, 2013.Granwehr BP, Merriman K, Grimes R, Torres HA, Mulanovich V, Routbort M, Chiao E. HIV Testing in a Cancer Center. ID week 2013. October 2-6, San Francisco, CA, 2013.Mahale P, Miller ED, Blechacz B, Herlong HF, Davila M, Torres HA. The end result of antiviral treatment on progression of liver illness in Hepatitis C Virus-infected clients with malignancies. The Liver Meeting®, AASLD’s 64th Annual Meeting in Washington, 2013.Torres HA, Mahale P, Kontoyiannis DP, Hollinger FB. Occult Hepatitis B and Occult Hepatitis C Viremia in Patients with Hematological Malignancies. Abstracts of the 2012 United states community medical Oncology. (ASCO) Annual Meeting, 6/2012.Torres HA, Mahale P. Does chemotherapy cause hepatitis C viral relapse in cancer customers which realized suffered virological reaction?. The Liver Meeting®, 2012.Mahale P, Kontoyiannis DP, Torres HA. Tall collective dosage of rituximab is of intense exacerbation of chronic hepatitis C virus infection in clients with cancer tumors. The Liver Meeting®, 2012.Hassabo MH, Iwasaki M, Soliman MK, Kaseb the, Torres HA, Li D, Xiao L, Abaza Yasmin, Morris J, Hassan M. influence of metformin on HCC prognosis in existence and lack of HCV infection. The Liver Meeting, 2012.Saxena A, Hassan M, Mahale P, Kontoyiannis DP, Torres HA. Testing for HCV disease in a National Cancer Institute-designated disease center. The Liver Meeting®, 2012.Torres HA, Kaseb A, Mahale P, Miller E, Frenette C. Telaprevir containing routine against hepatitis C virus infection in patients with hepatocellular carcinoma waiting for liver transplantation - an instance series. The Liver Meeting®, 2012.Torres HA, Mahale P, Saxena The, Afshar-Kharghan V, Kroll MH, Oo TH. Utilization of Growth aspects in Treatment of Hepatitis C Viral disease in Cancer Patients. 2012 yearly Meeting associated with the American Society of Hematology in Atlanta, 2012.Mahale P, Torres HA. Changes in Hepatitis C Virus RNA values in Cancer Patients Undergoing Chemotherapy or Immunosuppressive treatment. Abstracts regarding the 49th yearly Meeting of this Infectious Diseases Society of The united states, 2011.Torres HA, Davila M, Mulanovich VE, Granwehr BP, Miller E, Nevah MI, Mishra L, Kontoyiannis DP, Raad II. Hepatitis C Clinic at a thorough Cancer Center: The successful story of multidisciplinary attempts. Abstracts regarding the 49th yearly Meeting of the Infectious Diseases Society of America, 2011.Torres HA, Roach LR, Smith K, Mahale P, Raad II, Adachi JA. Increase price of customers with Hepatitis C illness addressed with antiviral treatment at MD Anderson Cancer Center. Abstracts of the 2011 University of Tx program Clinical protection and Effectiveness meeting, San Antonio, Texas, 2011.Torres HA, Mahale P, Ying J, Kontoyiannis DP. Rituximab and Gemcitabine are of Acute Exacerbation of Chronic Hepatitis C Virus disease in Patients with Cancer. Abstracts associated with 62nd yearly Meeting associated with the United states Association when it comes to learn of Liver Diseases. The Liver Meeting®, 2011.Mahale P, Kaseb AO, Davila M, Torres HA. The effect of transcatheter arterial chemoembolization on hepatitis c virus kinetics in customers with HCV associated hepatocellular carcinoma. Abstracts associated with 47th American community Clinical Oncology (ASCO) Annual Meeting, 2011.Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Mishra L, Hassan MM, Raad II. Variation of hepatitis C virus genotype distribution between geographically associated patients: A retrospective multicenter study. Abstracts of the 47th American Society medical Oncology (ASCO) Annual Meeting, 2011.Mahale P, Davila M, Chemaly RF, Lewis RE, Hwang JP, Kontoyiannis DP, Torres HA. Acute Exacerbation of Chronic Hepatitis C in Cancer Patients, 2010.Chitasombat MN, Jiang Y, Torres HA, Nguyen K, Tarrand J, Chemaly RF. Cytomegalovirus Infection in Patients with Chronic Lymphocytic Leukemia, 2010.Torres HA, Mahale P, Davila M, Mulanovich V, Granwehr B, Kontoyiannis DP, Raad II. Hepatitis C Virus disease in Cancer Patients: The Story of a Forgotten populace, 2010.Raad II, Ramos E, Hachem R, Jiang Y, Torres HA, Al-Akhrass F, Kontoyiannis DP, Safdar A. Are white-blood Cell Transfusions Useful in the Salvage remedy for Invasive Aspergillosis in Neutropenic Hematologic Malignancy people? (#M-1058), 2009.Rathod DB, Torres HA, Munsell M, Bodey G, Davis M, Saifan C, Raad II, Champlin R, Chemaly RF. Constant Versus Intermittent Dose Schedule of Aerosolized Ribavirin for remedy for Respiratory Syncytial Virus top respiratory system infection in customers with Hematological Malignancies: An Adaptive Randomized Trial. Abstracts associated with the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 2009.Hachem R, Ramos E, Kassis C, Jiang Y, Torres HA, Kontoyiannis D., Raad II. The Combination of Posaconazole and Echinocandins as Salvage treatment of Invasive Aspergillosis in Hematologic Malignancy Patients (#M-1046), 2009.Raad II, Hanna H, Boktour M, Torres HA, Kontoyiannis DP, Hachem R. The blend of Caspofungin and Voriconazole as Major and Salvage treatment of Invasive Aspergillosis in Hematologic Malignancy people, 2008.Torres HA, Aguilera EA, Rohatgi N, Raad II, Sepulveda C, Safdar the, Kontoyiannis DP, Chemaly RF. Cytomegalovirus Pneumonia in Patients with Hematologic Malignancies: An Autopsy-Based Case-Control Study (#787), 2007.Torres HA, Rodriguez G, Aguilera EA, Rohatgi N, Raad II, Safdar the, Chemaly RF. Cytomegalovirus Adrenalitis: A Challenging Diagnosis in Patients with Hematologic Malignancies (#1285), 2006.Torres HA, El-Osta H, Hachem RY, Mattiuzzi G, Cabanillas M, Jain the, Raad II, Chemaly RF. Parainfluenza Virus disease in Patients with Leukemia generally requires the Lower Respiratory Tract (#1286), 2006.Raad II, Hanna HA, Boktour MR, Torres HA, Kontoyiannis DP, Hachem RY. Posaconazole versus tall Dose Lipid Formulations of Amphotericin B as Salvage treatment for Invasive Aspergillosis in Patients with Hematologic Malignancy, 2006.Raad II, Hanna HA, Boktour MR, Torres HA, Kontoyiannis DP, Hachem RY. The mixture of Caspofungin and Voriconazole as main and Salvage Therapy of Invasive Aspergillosis in Hematologic Malignancy Patients, 2006.Hachem RY, Boktour MR, Hanna HA, Torres HA, Afif C, Kontoyiannis D, Raad II. Amphotericin B Lipid advanced vs. Liposomal Amphotericin B Monotherapy of Invasive Aspergillosis in Patients with Hematological Malignancy, 2005.Aisenberg GM, Torres HA, Tarrand J, Safdar A, Chemaly RF. Herpes Simplex Virus in Lower respiratory system Secretions in Patients with Solid Tumors: Shedding or disease?, 2005.Chemaly RF, Torres HA, Rohatgi N, Kontoyiannis DP, Safdar A, Kantarjian H, Daugherty T, Sepulveda C, Hachem R, Raad II. Human Herpesviruses-6 Viremia is of Donor Granulocyte Transfusions in Heavily Immunosuppressed people with Leukemia, 2005.Aguilera EA, Torres HA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Raad II, Chemaly RF. Influenza Disease In Mature Patients with Leukemia: The Impact Of Neuraminidase Inhibitors, 2005.Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Rohatgi N, Sepulveda C, Kantarjian H, Raad II, Chemaly RF. Respiratory Syncytial Virus disease in Patients With Leukemia: to deal with or perhaps not To Treat?, 2005.Torres HA, Cáceres AM, Simonovis N. C Reactive Protein in patients with Human Immunodeficiency Virus infection: prospective part in Diagnosis and track of Treatment, 2004.Torres HA, Younes the, Aguilera EA, Kontoyiannis DP, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus Infection in Patients with Lymphoma, 2004.Torres HA, Younes A, Aguilera EA, Rodríguez G, Luna MA, Tarrand JJ, Hachem RY, Nogueras GM, Raad II, Chemaly R. Cytomegalovirus Pneumonia in Patients with Lymphoma, 2004.Torres HA, Luna MA, Kontoyiannis DP, Tarrand JJ, Nogueras GM, Chemaly RF. Gastrointestinal Cytomegalovirus disorder in Patients with Cancer, 2004.Torres HA, Storey R, Chemaly RF, Aguilera EA, Luna MA, Rolston KVI, Raad II, Kontoyiannis DP. Pneumocystis Jiroveci Pneumonia in a Cancer Center: Influence of HIV Status to Presentation and Outcome, 2004.Aguilera EA, Torres HA, Gonzalez VR, Raad II, Chemaly RF. The Impact of Influenza Epidemic with a Predominant Mismatched Circulating stress using the Vaccine Strain on people with Hematologic Malignancies during Winter 2003-2004, 2004.Lionakis MS, Lewis RE, Torres HA, Kontoyiannis DP. In Vitro Susceptibility of Aspergillus Clinical Isolates to Amphotericin B, Itraconazole and Voriconazole by E-test together with aftereffect of Prior Antifungal Exposure (#2526), 2003.Pappas PG, Morgan J, Hajjeh RA, in addition to Transplant related disease Surveillance system (TRANSNET). Potential Surveillance for Invasive Fungal problems in Hematopoetic Stem Cell and Solid Organ Transplant Recipients in the United States (Preliminary Results) (#3826), 2003.Torres HA, Raad II, Reddy BT, Kontoyiannis DP. Pulmonary Cryptococcosis Due to Capsule-Deficient Cryptococcus Neoformans (#352), 2003.Torres HA, Rivero GA, Kontoyiannis DP. Endemic Mycoses in a Cancer Hospital (#6), 2002.Rolston KVI, Torres HA, Kontoyiannis DP. High Dose Fluconazole Therapy for Cancer Patients with Candidemia (#350), 2002.Antoniadou A, Torres HA, Lewis RE, Raad II, Thornby J, Tarrand J, Rolston KVI, Han XY, Bodey GP, Kontoyiannis DP. In vitro Susceptibility and opposition of Bloodstream Candida types in a Tertiary Care Cancer Center: Correlation with Outcome of Antifungal treatment (#M-1499), 2002.Lewis RE, Torres HA, May GS, Raad II, Thornby J, Rolston KVI, Updhyaya D, Bodey GP, Kontoyiannis DP. In vitro Susceptibility and Tolerance of Aspergillus Species in a Tertiary Care Cancer Center: Correlation with Invasive Aspergillosis and its Outcome (#M-1491), 2002.Rivero GA, Torres HA, Rolston KVI, Kontoyiannis DP. Listeriosis in Patients with Cancer (#187), 2002.Torres HA, Rolston KVI, Raad II, Kontoyiannis DP. Infections in customers with Aplastic Anemia: the knowledge of a Tertiary Care Cancer Center (#K-1244), 2001.Reddy BH, Torres HA, Raad II, Rolston KVI, Whimbey EE, Jacobson K, Tarrand JJ, Bodey GP, Kontoyiannis DP. Nocardiosis in Cancer customers (#67), 2001.Torres HA, Kontoyiannis DP. Protothecosis in Cancer Patients (#273), 2001.Torres HA, Narváez JC, Ortega J, Vielma L. Paracoccidioides Brasiliensis, Skin and Lung: an incident Report and post on the Literature, 1997.Torres HA, Kontoyiannis DP. Hyalohyphomycosis (besides Aspergillosis and Penicilliosis). In: Oxford Textbook of Clinical Mycology. Chapter 16. Ed(s) Dismukes WE, Pappas PG and Sobel JD. Oxford University Press: New York, NY, 252-270, 2011.Davila M, Torres, HA. Handling of Reactivation of Hepatitis B and Hepatitis C during antineoplastic therapy. In: Management of Infections in Cancer Patients, 1st. Humana Press: Nyc, 2011.Torres HA, Boeckh M, Chemaly RF. Viral Problems. In: Internal Drug Care of Cancer Individual. B C Decker Inc Publisher, 2009.Torres HA, Chemaly RF. Cytomegalovirus Pneumonia. In: Encyclopedia of Molecular Mechanisms of Disease. Springer Publishing House, 2007.Torres HA, Davila M. Authors' reply:. Current techniques in handling of hepatitis B virus reactivation. Nat Rev Clin Oncol 9(6):156-66, 2012.